Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation
- 2 November 2016
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 30 (4) , 347-359
Abstract
Detrimental impact of preformed donor-specific antibodies (DSAs) against human leucocyte antigens on outcomes after kidney transplantation are well documented, however, the value of their capacity to bind complement for predicting antibody-mediated rejection (AMR) and graft survival still needs to be confirmed. We aimed to study DSA characteristics (strength and C1q binding) that might distinguish harmful DSA from clinically irrelevant ones. We retrospectively studied 60 kidney-transplanted patients with preformed DSA detected by single antigen bead (SAB) assays (IgG and C1q kits), from a cohort of 517 kidney graft recipients (124 with detectable anti-HLA antibodies). Patients were divided into DSA strength (MFI < vs. ≥ 15 000) and C1q-binding ability. AMR frequency was high (30%) and it increased with DSA strength (P = 0.002) and C1q+ DSA (P < 0.001). The performance of DSA C1q-binding ability as a predictor of AMR was better than DSA strength (diagnostic odds ratio 16.3 vs. 6.4, respectively). Furthermore, a multivariable logistic regression showed that C1q+ DSA was a risk factor for AMR (OR = 16.80, P = 0.001), while high MFI DSAs were not. Graft survival was lower in high MFI C1q+ DSA in comparison with patients with C1q− high or low MFI DSA (at 6 years, 38%, 83% and 80%, respectively; P = 0.001). Both DSA strength and C1q-binding ability assessment seem valuable for improving pretransplant risk assessment. Since DSA C1q-binding ability was a better predictor of AMR and correlated with graft survival, C1q-SAB may be a particularly useful tool.Keywords
This publication has 33 references indexed in Scilit:
- Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipientsTransplant International, 2012
- Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney TransplantationAmerican Journal of Transplantation, 2011
- Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney TransplantationJournal of the American Society of Nephrology, 2010
- C4d-Fixing Capability of Low-Level Donor-Specific HLA Antibodies Is Not Predictive for Early Antibody-Mediated RejectionTransplantation, 2010
- Efficacy of Induction Therapy with ATG and Intravenous Immunoglobulins in Patients with Low‐Level Donor‐Specific HLA‐AntibodiesAmerican Journal of Transplantation, 2010
- Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working GroupsAmerican Journal of Transplantation, 2010
- Baseline Donor‐Specific Antibody Levels and Outcomes in Positive Crossmatch Kidney TransplantationAmerican Journal of Transplantation, 2010
- Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assayHuman Immunology, 2009
- Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevantHuman Immunology, 2009
- Improved Graft Survival in Highly Sensitized Patients Undergoing Renal Transplantation After the Introduction of a Clinically Validated Flow Cytometry CrossmatchTransplantation, 2009